Published December 2013 | Version v1
Journal article

A comparison of the gamma index analysis in various commercial IMRT/VMAT QA systems

  • 1. Centre for Nuclear and Radiation Physics, University of Surrey (United Kingdom)
  • 2. Department of Medical Physics, Royal Surrey County Hospital, Guildford (United Kingdom)
  • 3. School of Physics, University of Western Australia, Crawley (Australia)
  • 4. Department of Radiation Oncology, Sir Charles Gairdner Hospital, Nedlands (Australia)
  • 5. National Physical Laboratory, London (United Kingdom)

Description

Purpose: To investigate the variability of the global gamma index (γ) analysis in various commercial IMRT/VMAT QA systems and to assess the impact of measurement with low resolution detector arrays on γ. Materials: Five commercial QA systems (PTW 2D-Array, Scandidos Delta4, SunNuclear ArcCHECK, Varian EPID, and Gafchromic EBT2 film) were investigated. The response of γ analysis to deliberately introduced errors in pelvis and head and neck IMRT and RapidArc™ plans was evaluated in each system. A theoretical γ was calculated in each commercial QA system software (PTW Verisoft, Delta4 software, SNC Patient, Varian Portal Dosimetry and IBA OmniPro, respectively), using treatment planning system resolution virtual measurements and compared to an independent calculation. Error-induced plans were measured on a linear accelerator and were evaluated against the error-free dose distribution calculated using Varian Eclipse™ in the relevant phantom CT scan. In all cases, global γ was used with a 20% threshold relative to a point selected in a high dose and low gradient region. The γ based on measurement was compared against the theoretical to evaluate the response of each system. Results: There was statistically good agreement between the predicted γ based on the virtual measurements from each software (concordance correlation coefficient, ρc > 0.92) relative to the independent prediction in all cases. For the actual measured data, the agreement with the predicted γ reduces with tightening passing criteria and the variability between the different systems increases. This indicates that the detector array configuration and resolution have greater impact on the experimental calculation of γ due to under-sampling of the dose distribution, blurring effects, noise, or a combination. Conclusions: It is important to understand the response and limitations of the gamma index analysis combined with the equipment in use. For the same pass-rate criteria, different devices and software combinations exhibit varying levels of agreement with the predicted γ analysis

Availability note (English)

Available from http://dx.doi.org/10.1016/j.radonc.2013.08.048

Additional details

Identifiers

DOI
10.1016/j.radonc.2013.08.048;
PII
S0167-8140(13)00459-3;

Publishing Information

Journal Title
Radiotherapy and Oncology
Journal Volume
109
Journal Issue
3
Journal Page Range
p. 370-376
ISSN
0167-8140
CODEN
RAONDT

INIS

Country of Publication
Ireland
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
45096101
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
COMPARATIVE EVALUATIONS; ERRORS; HEAD; LINEAR ACCELERATORS; NECK; PELVIS; QUALITY ASSURANCE; RADIATION DOSE DISTRIBUTIONS; SPATIAL RESOLUTION
Descriptors DEC
ACCELERATORS; BODY; EVALUATION; RESOLUTION

Optional Information

Copyright
Copyright (c) 2013 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.